Revolutionary new drug that helps control nausea launched

Thursday March 24 2016

Mr Jaganathan Yuvaraj, CEO Devin Formulations,

Mr Jaganathan Yuvaraj, CEO Devin Formulations, India speaks at the Sarova Panafric Hotel on March 18, 2016 during the launch of a new drug dubbed Emifilm which is meant to help curb nausea in patients. PHOTO | COURTESY | NATION MEDIA GROUP 

More by this Author

Nausea has been one of the biggest nightmares for expectant women and cancer patients in Kenya.

It especially becomes challenging during the early stages of a pregnancy, in most cases becoming dangerous to the health of the mothers and well-being of the foetus.

For cancer patients, the most dreaded bit of chemotherapy is the nausea associated with it.

In bid to help control this, Numen Healthcare have launched a new drug to help control the nausea.

Dubbed Emifilm, the drug is meant to help curb nausea in the patients.

The orally disintegrating film (ODF), which currently retails at Sh100 was launched at the Sarova Panafric Hotel last Friday.

It comes in a 4mg strip and provides instant relief to nauseated patients.

For children, the recommended dosage is half of the film.

Speaking during the launch, Numen Healthcare Vice-President Chandra Mohan Kurup said the strip dissolves and melts in the mouth within five minutes, thus one does not have to use water to swallow.


He added that it can be used for the nausea and vomiting experienced before anaesthesia.

“It is also ideal for the nausea associated with chemotherapy.

“Once placed on the tongue it dissolves in the mouth within seconds.

“The film, which does not require water for administration, also acts fast and is recommended before meals for proper digestion,” said Kurup

“It is very convenient and easy to carry and transport. It is ideal for pre-gastric delivery and has a faster onset of action. It is also very stable in the mouth and cannot easily fall off,” he added.

Prof T S Chandrasekar, a celebrated gastroenterologist from India who was the chief guest, termed the new drug as revolutionary in the medical field.

“With the different changes evolving in the medical arena, I am sure that this drug will be ideal and in demand as nausea has been a major challenge in the treatment of patients,” he added.

Dr Vincent Wekesa, a neurosurgeon, termed it as a relief for his patients.

“I have been giving it to my patients and so far they have even been demanding for more. Yet I only give them thrice a day,” he added.